| 🟢 3 earning beats in the last 4 quarters 🟢 +3.74% price growth over the last year 🟢 Lower volatility than the market (beta 0.30) Technical Summary: Our systems currently rank Vertex Pharmaceuticals as hold candidate as upwards direction is not yet set. However, the stock has triggered buy signal from both the short and long moving avergae and have pivot buy signal in both RSI and main chart.
From Bollinger Bands the stock just gave a buy signal and upturns are often seen following a buy signal, especially if the stock is coming out from a neck formation (very thing channel). Some support at $420 and scattered resistance above offers a ok risk/reward. | 
